February 1, 2007

Bipolar Disorder Geodon Weight Loss Study at Stanford University

Geodon in Weight Loss Study for Bipolar Disorders

Stanford University (Palo Alto, California) has just started enrollment for a new research study at the Stanford University Bipolar Disorders Clinic. Here is some information on this study:

Stanford University is examining the use of ziprasidone (Geodon) in the treatment of patients currently experiencing possible weight gain due to use of a mood stabilizer and/or an antipsychotic in Bipolar Disorder. In this study, after an initial evaluation phase, patients will be instructed to replace Geodon for their current stable medication regimen for a period of 12 weeks while being monitored by a psychiatrist using clinical and laboratory measures. For additional information, please contact Kristine Keller at (650) 498-4968.

More information: Stanford University Bipolar Disorders Clinic

Comments

Post a comment


Type the characters you see in the picture above.

Remember Me?